What it is
Mechanism evidence: human
A CGM samples glucose in interstitial fluid through a skin sensor and estimates glucose values and trends. Interstitial readings can lag blood glucose, especially during rapid change.
What it is, why people use it, the evidence, and what to know before trying it.
Mechanism evidence: human
CGMs are established tools in diabetes care and selected OTC systems broaden access. For people without diabetes, data can be interesting but normal fluctuations are easy to over-interpret and proven outcome benefits remain limited.
Confidence: strong
Known limitations and precautions from reviewed sources.
Readings can be inaccurate or delayed, sensors can irritate skin, and some over-the-counter systems do not provide urgent low-glucose alerts. Symptoms and treatment decisions may require confirmatory testing and clinical guidance.